Adlai Nortye (ANL) Total Non-Current Liabilities (2022 - 2025)

Adlai Nortye (ANL) reported Total Non-Current Liabilities of $1.1 million for Q4 2025, up 165.18% year-over-year from $425000.0 in Q4 2024, and up 338.52% on a QoQ basis from $257000.0 in Q2 2025.

Adlai Nortye (ANL) has 4 years of Total Non-Current Liabilities data on file, last reported at $1.1 million in Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 165.18% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (up 165.18% YoY) and the FY2025 annual result came in at $1.1 million, up 165.18% from the prior year.
  • Total Non-Current Liabilities advanced to $1.1 million in Q4 2025 per ANL's latest filing, from $257000.0 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $5.5 million in Q4 2023 and bottomed at $257000.0 in Q2 2025.
  • The 4-year median for Total Non-Current Liabilities is $1.1 million (2025), against an average of $1.7 million.
  • The widest annual swing landed in 2023, when Total Non-Current Liabilities soared 342.48%; it then tumbled 92.23% in 2024.
  • Tracing ANL's Total Non-Current Liabilities over 4 years: stood at $1.2 million in 2022, then soared by 342.48% to $5.5 million in 2023, then plunged by 92.23% to $425000.0 in 2024, then surged by 165.18% to $1.1 million in 2025.
  • Per Business Quant, the three latest ANL Total Non-Current Liabilities figures stand at $1.1 million (Q4 2025), $257000.0 (Q2 2025), and $425000.0 (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 11.03 Mn
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - 42,980.09
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 95.20 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - 110.28 Mn
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 5.87 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 7.32 Bn
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 4.05 Bn
10 Adlai Nortye 23,840.00 -8.03 Mn - 1.13 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.13 Mn
Jun 30, 2025 257,000.00
Dec 31, 2024 425,000.00
Dec 31, 2023 5.47 Mn
Dec 31, 2022 1.24 Mn